Evidence map›Paper›PMID 40180136›Full record

ReviewBiotechnology advances

Taking the 3Rs to a higher level: replacement and reduction of animal testing in life sciences in space research.

Mathieu Vinken, Daniela Grimm, Sarah Baatout, Bjorn Baselet, Afshin Beheshti, Markus Braun, Anna Catharina Carstens, James A Casaletto, Ben Cools, Sylvain V Costes and 23 more

Abstract readReview
In one paragraph

Review in Biotechnology advances. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

Mathieu VinkenDepartment of Pharmaceutical and Pharmacological Sciences, Vrije Universiteit Brussel, Brussels, Belgium. Electronic address: mathieu.vinken@vub.be.
Daniela GrimmDepartment of Microgravity and Translational Regenerative Medicine, Otto-von-Guericke-University, Magdeburg, Germany; Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Sarah BaatoutNuclear Medical Applications Institute, Belgian Nuclear Research Centre, Mol, Belgium; Department of Molecular Biotechnology, Gent University, Gent, Belgium.
Bjorn BaseletNuclear Medical Applications Institute, Belgian Nuclear Research Centre, Mol, Belgium.
Afshin BeheshtiCenter of Space Biomedicine, McGowan Institute for Regenerative Medicine, and Department of Surgery, University of Pittsburgh, Pittsburgh, PA, USA; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Markus BraunGerman Space Agency, German Aerospace Center, Bonn, Germany.
Anna Catharina CarstensGerman Space Agency, German Aerospace Center, Bonn, Germany.
James A CasalettoBlue Marble Space Institute of Science, Space Biosciences Division, NASA Ames Research Center, Moffett Field, CA, USA.
Ben CoolsDepartment of Pharmaceutical and Pharmacological Sciences, Vrije Universiteit Brussel, Brussels, Belgium; Nuclear Medical Applications Institute, Belgian Nuclear Research Centre, Mol, Belgium.
Sylvain V CostesBlue Marble Space Institute of Science, Space Biosciences Division, NASA Ames Research Center, Moffett Field, CA, USA; Space Biosciences Division, NASA Ames Research Center, Moffett Field, CA, USA.
Phoebe De MeulemeesterDepartment of Pharmaceutical and Pharmacological Sciences, Vrije Universiteit Brussel, Brussels, Belgium.
Bartu DorukSpace Applications Services NV/SA, Sint-Stevens-Woluwe, Belgium; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.
Sara EyalInstitute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
Miguel J S FerreiraSpace Applications Services NV/SA, Sint-Stevens-Woluwe, Belgium.
Silvana MirandaNuclear Medical Applications Institute, Belgian Nuclear Research Centre, Mol, Belgium; Department of Molecular Biotechnology, Gent University, Gent, Belgium.
Christiane HahnEuropean Space Agency, Human and Robotic Exploration Programmes, Human Exploration Science team, Noordwijk, the Netherlands.
Sinem Helvacıoğlu AkyüzDepartment of Pharmaceutical and Pharmacological Sciences, Vrije Universiteit Brussel, Brussels, Belgium.
Stefan HerbertSpace Systems, Airbus Defence and Space, Immenstaad am Bodensee, Germany.
Dmitriy KrepkiyOffice of Special Initiatives, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA.
Yannick LichterfeldDepartment of Applied Aerospace Biology, Institute of Aerospace Medicine, German Aerospace Center, Cologne, Germany.
Christian LiemersdorfDepartment of Applied Aerospace Biology, Institute of Aerospace Medicine, German Aerospace Center, Cologne, Germany.
Marcus KrügerDepartment of Microgravity and Translational Regenerative Medicine, Otto-von-Guericke-University, Magdeburg, Germany.
Shannon MarchalDepartment of Microgravity and Translational Regenerative Medicine, Otto-von-Guericke-University, Magdeburg, Germany.
Jette RitzDepartment of Pharmaceutical and Pharmacological Sciences, Vrije Universiteit Brussel, Brussels, Belgium.
Theresa SchmakeitDepartment of Applied Aerospace Biology, Institute of Aerospace Medicine, German Aerospace Center, Cologne, Germany.
Hilde StenuitSpace Applications Services NV/SA, Sint-Stevens-Woluwe, Belgium.
Kevin TaburyNuclear Medical Applications Institute, Belgian Nuclear Research Centre, Mol, Belgium.
Torsten TrittelDepartment of Microgravity and Translational Regenerative Medicine, Otto-von-Guericke-University, Magdeburg, Germany; Department of Engineering, Brandenburg University of Applied Sciences, Brandenburg an der Havel, Germany.
Markus WehlandDepartment of Microgravity and Translational Regenerative Medicine, Otto-von-Guericke-University, Magdeburg, Germany.
Yu Shrike ZhangDivision of Engineering, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Karson S PuttInstitute for Drug Discovery, Purdue University, West Lafayette, IN, USA.
Zhong-Yin ZhangInstitute for Drug Discovery, Purdue University, West Lafayette, IN, USA; Borch Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN, USA.
Danilo A TagleOffice of Special Initiatives, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA.

Funding

Structure/Function of Protein Tyrosine PhosphatasesR01CA069202 · NCI · YESHIVA UNIVERSITY · PI Zhong-Yin Zhang · 1996 to 2026
$7.3M
High-throughput Imaging-integrated Vascular Model for Understanding Thromboembolism and Therapeutics ScreeningR01HL166522 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI Junjie Yao, Y. Shrike Zhang · 2023 to 2026
$2.7M
Biomaterials for embolization and ablation of arterio-venous malformationsR01HL165176 · NHLBI · MAYO CLINIC ARIZONA · PI OKLU, RAHMI, ZHANG, Y. SHRIKE · 2022 to 2025
$2.6M
"Clinical Trials" on a Premature Vascular Aging-on-a-Chip ModelUH3TR003274 · NCATS · BRIGHAM AND WOMEN'S HOSPITAL · PI ZHANG, Y. SHRIKE · 2022 to 2024
$1.8M
A Bioprinted Volumetric Model of Vascularized GlioblastomaR01CA282451 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI Kaisorn Lee Chaichana, Y. Shrike Zhang · 2023 to 2026
$1.7M
Primary screening and hit follow up to identify the first selective inhibitors of PLC?1 and PLC?2R01CA295436 · NCI · PURDUE UNIVERSITY · PI Zhong-Yin Zhang · 2025 to 2026
$1.1M
Modeling Sex-Specific Cardiac Hypertrophy-on-a-ChipR21HL168656 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI MAHARJAN, SUSHILA, ZHANG, Y. SHRIKE · 2024 to 2025
$492k
NCATS NIH HHS UH3 TR003274NCI NIH HHS R01 CA069202NCI NIH HHS R01 CA282451NCI NIH HHS R01 CA295436NHLBI NIH HHS R01 HL165176NHLBI NIH HHS R01 HL166522NHLBI NIH HHS R21 HL168656
6 · The paper itself

Abstract

Human settlements on the Moon, crewed missions to Mars and space tourism will become a reality in the next few decades. Human presence in space, especially for extended periods of time, will therefore steeply increase. However, despite more than 60 years of spaceflight, the mechanisms underlying the effects of the space environment on human physiology are still not fully understood. Animals, ranging in complexity from flies to monkeys, have played a pioneering role in understanding the (patho)physiological outcome of critical environmental factors in space, in particular altered gravity and cosmic radiation. The use of animals in biomedical research is increasingly being criticized because of ethical reasons and limited human relevance. Driven by the 3Rs concept, calling for replacement, reduction and refinement of animal experimentation, major efforts have been focused in the past decades on the development of alternative methods that fully bypass animal testing or so-called new approach methodologies. These new approach methodologies range from simple monolayer cultures of individual primary or stem cells all up to bioprinted 3D organoids and microfluidic chips that recapitulate the complex cellular architecture of organs. Other approaches applied in life sciences in space research contribute to the reduction of animal experimentation. These include methods to mimic space conditions on Earth, such as microgravity and radiation simulators, as well as tools to support the processing, analysis or application of testing results obtained in life sciences in space research, including systems biology, live-cell, high-content and real-time analysis, high-throughput analysis, artificial intelligence and digital twins. The present paper provides an in-depth overview of such methods to replace or reduce animal testing in life sciences in space research.

Indexed as

Animal Testing AlternativesBiological Science DisciplinesSpace FlightAnimalsHumansArtificial intelligenceBioprintingDigital twinsHigh-throughput screeningLive-cell, high-content and real-time analysisMicrogravity and radiation simulatorsMicrophysiological systemPrimary cells and stem cellsSpheroids and organoidsSystems biology

Identifiers

PMID40180136
PMCPMC12048243

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.